CLINICAL_TRIALS trial_result · 2026-03-11

Clinical Trial Update: Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma [Phase 2]

Olaparib was evaluated in a Phase 2 trial for advanced pancreatic acinar cell carcinoma, but the study was terminated and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: National Cancer Institute (NCI) | Conditions: Pancreatic Acinar Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2026-03-11